Similar to the results of training and testing sets, the extended set data showed significantly elevated plasma TP73‐AS1 and CRNDE levels in patients with NSCLC compared to patients with COPD and those with pneumonia (all p < 0.001; Figure 4A,B). The gene discussed is TP73; the disease is non-small cell lung carcinoma.